|
Equity (Schedule of Outstanding Warrants) (Details) (USD $)
|
0 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | 9 Months Ended | 12 Months Ended | 1 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 24, 2016
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2013
Series BB Warrants [Member]
|
Dec. 31, 2013
Series EE Warrants [Member]
|
Dec. 31, 2013
Series FF Warrants [Member]
|
Dec. 31, 2013
Series GG Warrants [Member]
|
Dec. 31, 2013
Series HH Warrants [Member]
|
Jun. 30, 2013
Series HH Warrants [Member]
|
Jun. 30, 2013
Five Year Series II Warrants [Member]
|
Dec. 31, 2013
Five Year Series II Warrants [Member]
|
Dec. 31, 2013
Three Year Series JJ Warrants [Member]
|
Sep. 30, 2013
Three Year Series JJ Warrants [Member]
|
Dec. 31, 2013
Series W Warrants [Member]
|
Dec. 31, 2013
Maximum [Member]
|
Jun. 30, 2013
Maximum [Member]
Five Year Series II Warrants [Member]
|
Sep. 30, 2013
Maximum [Member]
Three Year Series JJ Warrants [Member]
|
Sep. 30, 2013
Platinum Montaur Life Sciences Llc Credit Facility [Member]
|
Dec. 31, 2013
Platinum Montaur Life Sciences Llc Credit Facility [Member]
|
Mar. 31, 2013
Platinum Montaur Life Sciences Llc Credit Facility [Member]
Series X Warrants [Member]
|
Dec. 31, 2013
Platinum Montaur Life Sciences Llc Credit Facility [Member]
Series X Warrants And Series Aa Warrants [Member]
|
Jun. 30, 2013
Platinum Montaur Life Sciences Llc Credit Facility [Member]
Series X Warrants And Series Aa Warrants [Member]
|
Jun. 30, 2013
General Electric Capital Corporation [Member]
Series HH Warrants [Member]
|
Jun. 25, 2013
General Electric Capital Corporation [Member]
Series HH Warrants [Member]
|
Jun. 30, 2013
Preferred Stock [Member]
|
Dec. 31, 2013
Preferred Stock [Member]
|
Jun. 30, 2013
Common Stock [Member]
|
Dec. 31, 2013
Common Stock [Member]
|
|
| Class of Warrant or Right [Line Items] | |||||||||||||||||||||||||||||
| Warrants exercised | 6,000,000 | 3,000,000 | |||||||||||||||||||||||||||
| Warrants, number of securities called by warrants | 301,205 | 275,000 | 3,169,015 | 3,800,000 | 301,205 | ||||||||||||||||||||||||
| Exercise Price | 3.39 | 2.00 | 2.375 | 1.97 | 2.10 | 2.49 | 3.04 | 3.83 | 3.83 | 3.83 | 3.04 | 3.83 | 2.49 | 2.49 | |||||||||||||||
| Class of Warrant or Right, Term | 5 years | ||||||||||||||||||||||||||||
| Number of Warrants | 4,542,764 | 300,000 | 134,211 | 30,000 | 333,333 | 301,205 | 275,000 | 3,169,015 | |||||||||||||||||||||
| Expiration Date | Sep. 24, 2016 | Jul. 07, 2015 | Aug. 09, 2015 | Dec. 01, 2015 | Dec. 29, 2016 | Jun. 25, 2023 | Jun. 25, 2018 | Sep. 24, 2016 | |||||||||||||||||||||
| Issued stock upon exercise of warrants, net, shares | 6,000,000 | 3,000,000 | |||||||||||||||||||||||||||
| Proceeds from Warrant Exercises | $ 1,920,000 | $ 1,380,000 | |||||||||||||||||||||||||||
| Conversion of Series B preferred stock to common stock, shares | 2,364.9 | 2,364.9 | |||||||||||||||||||||||||||
| Number of common shares underlying Series B Preferred Stock | 7,733,223 | 7,733,223 | |||||||||||||||||||||||||||
| Shares conversion, number of common stock equivalent to each preferred stock | 3,270 | 3,270 | |||||||||||||||||||||||||||
| Repayments of Notes Payable | $ 5,982,155 | $ 1,285,046 | $ 62,411 | $ 4,781,333 | $ 4,800,000 | ||||||||||||||||||||||||